[1]
Prigenzi, K.C.K. et al. 2026. Human epidermal growth factor receptor-type 2 status and tumor heterogeneity in invasive breast carcinomas: clinical pathological impact. Mastology. 35, suppl.1 (Feb. 2026). DOI:https://doi.org/10.29289/259453942025V35S1041.